- Golden Corral coming to Cape; may hire 100 workers (7/21/16)8
- Arrest warrants filed for six drug suspects in Cape (7/19/16)6
- Area groups working together to reintroduce elk in Missouri (7/18/16)1
- Suspect in downtown Cape shooting ID'd in court (7/20/16)2
- Prosecutor says shooting by state trooper was justified (7/24/16)14
- Pincksten's newest renovation project: 328 S. Spanish St. (7/17/16)6
- Trooper-involved homicide case rests in prosecutor's hands (7/17/16)15
- Hastings in Cape closing (7/22/16)5
- Jackson's former police dog euthanized Monday (7/21/16)1
- 'I want to see how far I can go' (7/21/16)2
Exercise, healthy weight may prevent cancer
WASHINGTON -- Exercising and maintaining a healthful weight when young can delay the onset of breast cancer in women at very high risk of the disease, according to a study of women with a genetic mutation that gives them an 82 percent lifetime risk of developing the disease.
Researchers also found that women with mutations in the BRCA1 or BRCA2 gene have a 23 percent to 54 percent risk of ovarian cancer, depending on which gene is affected.
The study, appearing today in the journal Science, showed that lifestyle during adolescence played a role in when these high-risk women developed breast cancer. The finding was consistent with earlier studies suggesting that among women in general, exercise and healthy weight early in life can reduce a woman's risk of developing breast cancer after menopause.
"The possibility that lifestyle changes such as increased exercise and weight control could modify the impact of genetic risk has very intriguing implications, not only for BRCA-related cancers but for other breast cancers as well," said Dr. Larry Norton, head of the division of solid tumor oncology at Memorial Sloan-Kettering Cancer Center.
In the new study, women who exercised actively when they were young -- either dancing, or in team sports, or just walking a lot -- and who maintained a healthful weight -- that is, they were not obese -- through the age of 21, were somewhat protected from breast cancer, said Mary-Claire King, first author of the study and a professor of genome sciences at the University of Washington-Seattle.
"If they carried the mutation, they still had a very high risk, but their age of diagnosis was pushed to later in life," she said.
Earlier studies had suggested that women with the gene mutations have a risk ranging from 25 percent to 80 percent of developing breast cancer in their lives. The new study estimates the risk at 82 percent.
For ovarian cancer, which has also been linked to the gene mutations, the study found the lifetime risk was 54 percent for BRCA1 and 23 percent for BRCA2 mutations. This compares with a risk for the general population of about 1.8 percent.
Researchers analyzed genes from 1,008 Ashkenazi Jewish women who had breast cancer and found that 104 of the patients had a mutation in the BRCA1 or BRCA2 gene. Half of the women had no immediate female relatives with breast or ovarian cancer, suggesting most of those women inherited the mutated gene from their fathers, the researchers said.
The researchers then analyzed the BRCA genes for 2,000 people in the families of the breast cancer patients.
Based on the findings, the scientist estimated that women with one of the mutations have a:
For women in general, the risk of breast cancer over a lifetime is about 10 percent. Among breast cancer patients generally, only 5 percent to 10 percent have the inherited BRCA mutation.
The study also found that breast cancer risks were significantly higher for women who had the mutation and were born after 1940 than those in the same family born before that year, suggesting nongenetic influences -- such as an early first pregnancy, already known to reduce a woman's risk of breast cancer -- in development of the cancer.
The study looked at patients from 12 cancer centers in New York who were diagnosed with breast cancer between 1996 and 2000. The women were of European Jewish heritage because that population is known to harbor only three types of BRCA mutation. King said this limited variety of mutations made the complex study "technically more feasible."
The study said, however, that the results are probably applicable to any women with BRCA1 and BRCA2 mutations "who have similar lifestyles."